These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 7621283)

  • 1. [Somatostatin and biliary lithogenesis].
    Rodríguez JM; Targarona EM; Martínez J; Marco C; Trías M
    Gastroenterol Hepatol; 1995 Feb; 18(2):91-3. PubMed ID: 7621283
    [No Abstract]   [Full Text] [Related]  

  • 2. Gallstones during octreotide therapy.
    Dowling RH; Hussaini SH; Murphy GM; Wass JA
    Digestion; 1993; 54 Suppl 1():107-20. PubMed ID: 8103009
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of short-term octreotide therapy and total parenteral nutrition on the development of biliary sludge and lithiasis.
    Baudet S; Medina C; Vilaseca J; Guarner L; Sureda D; Andreu J; Malagelada JR
    Hepatogastroenterology; 2002; 49(45):609-12. PubMed ID: 12063951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights on SOM230, a universal somatostatin receptor ligand.
    Boerlin V; van der Hoek J; Beglinger Ch; Poon KW; Hartmann S; Dutreix C; Kovarik JM; Bruns Ch; Weckbecker G; Lewis I; Schnieper P; Hofland LJ; Lamberts SW
    J Endocrinol Invest; 2003; 26(8 Suppl):14-6. PubMed ID: 15233205
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatostatin and its analogues in G.I. tract, liver and pancreatic disorders.
    Dhar A; Chawla YK
    Trop Gastroenterol; 1995; 16(3):3-7. PubMed ID: 8838035
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholelithiasis in a newborn following treatment with the somatostatin analogue octreotide.
    Radetti G; Gentili L; Paganini C; Messner H
    Eur J Pediatr; 2000 Jul; 159(7):550. PubMed ID: 10923237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial: The effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices.
    Vlachogiannakos J; Kougioumtzian A; Triantos C; Viazis N; Sgouros S; Manolakopoulos S; Saveriadis A; Markoglou C; Economopoulos T; Karamanolis DG
    Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1479-87. PubMed ID: 17919272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current alternative in the pharmacotherapy of acromegaly: the long-acting somatostatin analogue octreotide].
    Laczi F; Magony S; Julesz J
    Orv Hetil; 2002 May; 143(19 Suppl):1062-6. PubMed ID: 12063861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gall stones and treatment with octreotide for acromegaly.
    BMJ; 1989 Nov; 299(6708):1162-3. PubMed ID: 2513036
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dilated cardiomyopathy in acromegaly worsening under octreotide treatment. Apropos of a case].
    Leclercq F; Fille A; Albat B; Beigbeder JY; Messner P; Thévenet A; Bringer J; Grolleau R
    Ann Cardiol Angeiol (Paris); 1993 Mar; 42(3):151-4. PubMed ID: 8498802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly.
    Ma P; Wang Y; van der Hoek J; Nedelman J; Schran H; Tran LL; Lamberts SW
    Clin Pharmacol Ther; 2005 Jul; 78(1):69-80. PubMed ID: 16003295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegvisomant: new preparation. A last resort in acromegaly.
    Prescrire Int; 2005 Feb; 14(75):10-3. PubMed ID: 15751152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gall stones induced by octreotide.
    Catnach SM; Wass JA; Anderson JV; Besser M; Fairclough P; Hussaini H; Dowling H
    BMJ; 1992 Aug; 305(6848):313. PubMed ID: 1392873
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-surgical management of a lymphatic fistula, after laparoscopic colorectal surgery, with total parenteral nutrition, octreotide, and somatostatin.
    Giovannini I; Giuliante F; Chiarla C; Ardito F; Vellone M; Nuzzo G
    Nutrition; 2005 Oct; 21(10):1065-7. PubMed ID: 16157245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slow intestinal transit and gallstone formation.
    Hussaini SH; Pereira SP; Dowling RH; Wass JA
    Lancet; 1993 Mar; 341(8845):638. PubMed ID: 8094871
    [No Abstract]   [Full Text] [Related]  

  • 16. Biliary colic on abrupt withdrawal of octreotide.
    James RA; Rhodes M; Rose P; Kendall-Taylor P
    Lancet; 1991 Dec; 338(8781):1527. PubMed ID: 1683947
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormal liver function tests in a patient fed with total parenteral nutrition and treated with octreotide.
    Crook MA; Steger A
    Nutrition; 2001 Feb; 17(2):152-4. PubMed ID: 11240342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of long-acting somatostatin analogue therapy.
    Jackson JA
    Am J Med; 1989 Apr; 86(4):512-3. PubMed ID: 2929652
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biliary lithogenesis. I. Etiologic factors, composition of the calculi, conditions of lithiasic precipitation].
    Debray C; Cerf M
    Presse Med (1893); 1968 May; 76(24):1171-4. PubMed ID: 5673384
    [No Abstract]   [Full Text] [Related]  

  • 20. [Black biliary stone: structure, components and lithogenesis].
    Wang XG; Shi YM; Hu XY
    Zhonghua Wai Ke Za Zhi; 1985 Sep; 23(9):522-4, 571. PubMed ID: 4092558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.